Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis
Clinical trial NCT05569538 · UNKNOWN
Trial details
- NCT number
- NCT05569538
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.